Ferrari files a patent application for vehicle with movable driver’s station

Published by Linda Raj on

Ferrari files a patent application for vehicle with movable driver’s station

Ferrari has filed a patent application for innovative cabin configurability, allowing drivers to freely adjust controls and seat positioning for various driving scenarios. Basically, for the configurable cabin to work, Ferrari incorporates advanced wire-controlled systems. (Source- carbuzz)

ABVC BioPharma receives a patent for the treatment of Major Depressive Disorder (MDD)

ABVC BioPharma has received an Australian patent, valid until 2040 for the use of PDC-1421, a Radix Polygala (Polygala tenuifolia Willd) extract for the treatment of Major Depressive Disorder (MDD). The Company was awarded a US patent, on April 25, 2023, for the same treatment. (Source- finance.yahoo)

Quant receives a patent for chronologically ordering blockchain transactions

Quant has secured a patent for chronologically ordering transactions from different blockchains. This patent recognises that Quant has introduced a method to agree on a universal time zone for all blockchains, so that enterprises and smaller businesses can produce reliable, consensus-based records. (Source- financialit)

SaverOne receives a patent for its transportation safety solution

SaverOne has received a patent for a system and method to facilitate safe driving. The patent describes advanced algorithms and selective blocking mechanism to prevent the driver from accessing distracting phone functionalities while the vehicle is in motion. (Source- prnewswire)

Adial Pharmaceuticals secures a patent for Alcohol Use Disorder (AUD) treatment

Adial Pharmaceuticals has received a patent regarding a genetic diagnostic tool used in conjunction with AD04, its lead drug candidate for alcohol use disorder (AUD) and potential drug dependencies such as opioid use disorder (OUD). (Source- investing)

Seekr Civility Score™ receives a patent for automatic scoring and analysis of audio content

Seekr has received a patent for a novel scoring system that identifies personal attacks in online audio content. Seekr AI contextually evaluates audio and generates a Civility Score™ that reflects the volume and severity of attacks within each piece of content. (Source- prnewswire)

Calliditas Therapeutics receives a patent for TARPEYO

Calliditas Therapeutics has received a patent for its product TARPEYO. The patent specifically pertains to a method of treating IgA nephropathy using TARPEYO® (budesonide) delayed release capsules, previously developed under the name NEFECON®. (Source – investing)

GeoVax announces multiple patent issuances and allowances

GeoVax Labs has received multiple patents from different patent offices. One among them is a Japanese patent that describes compositions and methods for generating an immune response to a tumor associated antigen. (Source- globenewswire)

 


Linda Raj

Linda, Lead Patent Scientist at DexPatent, is dedicated to aiding IP Counsel and Patent attorneys in Patent research and management. Her interests span from reading books to writing on subjects related to innovation, work, and life.

0 Comments

Leave a Reply

Avatar placeholder

Your email address will not be published. Required fields are marked *

Explore Featured Articles

Head-up Display Report- Competitive intelligence alert-Jan-2019

Head-up Display Report- Competitive intelligence alert-Jan-2019

Blue Eye Soft announces patent award for artificial intelligence technology

Blue Eye Soft announces patent award for artificial intelligence technology

Patenting Trends on Medical Drones – November 15 to 30

Patenting Trends on Medical Drones – November 15 to 30

Centered Image

Patent Newz Box is a collection of carefully handpicked Patent & IP news items delivered fortnightly, straight to your inbox, It helps you to stay on top of Global Patent News.

fast
Consistent

DexPatent consistently delivers high-quality reports.

fast
Reliable

DexPatent is a trusted partner for many MNCs and law firms.

fast
Fast

DexPatent’s quick response shows we respect your time.

Get in touch with us

Get a Quote

Please check your answer
Schedule a Call

Schedule a Call